bf/NYSE:ENZ_icon.jpeg

NYSE:ENZ

Enzo Biochem

  • Stock

USD

Last Close

1.15

30/08 20:00

Market Cap

55.57M

Beta: 1.04

Volume Today

11.45K

Avg: 874.22K

PE Ratio

2.37

PFCF: −1.38

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jul '14
Jul '15
Jul '16
Jul '17
Jul '18
Jul '19
Jul '20
Jul '21
Jul '22
Jul '23
average inventory
8.75M
-
8.04M
8.05%
7.18M
10.69%
7.01M
2.43%
7.16M
2.19%
7.56M
5.55%
7.81M
3.35%
10.22M
30.78%
14.03M
37.32%
11.68M
16.79%
average payables
8.36M
-
8.50M
1.68%
9.31M
9.48%
10.10M
8.53%
9.93M
1.69%
8.39M
15.57%
7.88M
6.04%
8.31M
5.50%
8.32M
0.03%
6.04M
27.35%
average receivables
12.38M
-
15.61M
26.14%
16.68M
6.79%
14.89M
10.73%
14.16M
4.85%
11.94M
15.68%
9.94M
16.77%
9.67M
2.72%
10.86M
12.28%
8.16M
24.82%
book value per share
0.87
-
0.94
8.20%
1.94
106.56%
1.92
1.18%
1.73
9.93%
1.82
5.20%
1.22
32.63%
1.42
16.27%
1.12
21.25%
1.60
42.41%
capex per share
-0.02
-
-0.04
99.66%
-0.03
15.67%
-0.04
14.09%
-0.04
6.27%
-0.17
326.96%
-0.05
73.49%
-0.09
102.32%
-0.07
22.38%
-0.06
21.42%
capex to depreciation
-0.21
-
-0.47
122.99%
-0.40
15.33%
-0.49
22.28%
-0.60
23.80%
-2.68
343.73%
-0.78
70.84%
-1.67
114.21%
-1.23
26.55%
-1.03
16.21%
capex to operating cash flow
0.49
-
0.48
2.41%
-0.03
105.98%
8.55
29,792.29%
0.69
91.93%
-1.69
344.93%
0.13
107.47%
-11.46
9,174.42%
0.21
101.83%
0.07
64.33%
capex to revenue
-0.01
-
-0.02
109.17%
-0.01
18.51%
-0.02
9.23%
-0.02
10.88%
-0.10
455.24%
-0.03
71.49%
-0.04
32.00%
-0.03
13.94%
-0.09
174.02%
cash per share
0.41
-
0.40
2.64%
1.47
267.80%
1.38
5.73%
1.28
7.67%
1.27
0.63%
1.00
20.99%
0.90
10.05%
0.44
50.75%
1.68
276.91%
days of inventory on hand
58.45
-
49.29
15.67%
44.49
9.73%
43.25
2.80%
43.99
1.73%
49.42
12.33%
54.38
10.03%
71.98
32.38%
86.40
20.03%
148.64
72.04%
days payables outstanding
55.45
-
58.39
5.29%
62.91
7.74%
63.52
0.96%
57.52
9.44%
45.72
20.51%
59.40
29.90%
46.22
22.19%
47.70
3.21%
66.93
40.32%
days sales outstanding
47.44
-
70.15
47.89%
51.82
26.13%
51.40
0.83%
45.83
10.84%
48.29
5.37%
43.89
9.11%
31.62
27.96%
39.26
24.17%
56.50
43.92%
debt to assets
0.06
-
0.05
17.95%
0.02
58.11%
0.01
75.77%
0.00
34.76%
0.04
1,143.07%
0.29
575.03%
0.20
31.55%
0.21
7.68%
0.06
73.27%
debt to equity
0.11
-
0.08
24.44%
0.03
67.42%
0.01
76.49%
0.00
32.51%
0.05
1,129.59%
0.56
949.71%
0.33
41.13%
0.38
14.33%
0.09
76.41%
dividend yield
earnings yield
-0.05
-
-0.02
65.61%
0.15
969.47%
-0.00
103.41%
-0.05
898.40%
-0.53
973.27%
-0.30
44.04%
0.02
107.30%
-0.19
980.66%
0.28
245.24%
enterprise value
190.95M
-
121.54M
36.35%
244.83M
101.43%
439.30M
79.43%
147.93M
66.33%
129.60M
12.39%
98.44M
24.04%
166.25M
68.89%
116.58M
29.88%
-2.62M
102.25%
enterprise value over ebitda
157.81
-
-66.74
142.29%
2.38
103.57%
4.08
71.06%
1.41
65.33%
1.60
13.02%
-6.55
510.11%
13.27
302.62%
-10.64
180.19%
0.22
102.03%
ev to operating cash flow
-112.52
-
-32.85
70.81%
4.61
114.03%
-2.14K
46,600.58%
-54.09
97.48%
26.97
149.86%
-5.73
121.25%
429.60
7,596.92%
-7.03
101.64%
0.07
101.01%
ev to sales
1.99
-
1.25
37.43%
2.38
91.29%
4.08
71.06%
1.41
65.33%
1.60
13.02%
1.29
18.90%
1.41
9.05%
1.09
22.90%
-0.08
107.74%
free cash flow per share
-0.06
-
-0.12
102.97%
1.12
1,024.75%
-0.04
103.78%
-0.10
132.98%
-0.07
28.76%
-0.41
478.59%
-0.08
79.29%
-0.41
391.37%
-0.81
95.79%
free cash flow yield
-0.01
-
-0.04
224.75%
0.17
512.83%
-0.00
102.34%
-0.02
471.91%
-0.02
19.47%
-0.17
850.53%
-0.03
84.88%
-0.17
561.93%
-0.55
220.14%
graham net net
0.09
-
0.22
156.45%
1.30
483.88%
1.30
0.14%
1.13
13.24%
1.09
3.59%
0.09
91.41%
0.26
174.80%
-0.07
127.65%
0.95
1,433.38%
graham number
2.14
-
1.03
51.78%
6.55
534.27%
1.53
76.67%
2.92
91.40%
9.23
216.04%
4.42
52.10%
1.51
65.90%
3.42
126.89%
3.85
12.47%
income quality
0.17
-
1.62
851.99%
1.17
27.55%
0.08
93.02%
0.26
223.68%
1.93
628.66%
0.60
68.80%
0.05
91.84%
0.91
1,748.68%
-1.82
300.61%
intangibles to total assets
0.24
-
0.20
17.64%
0.11
46.63%
0.10
9.50%
0.09
4.42%
0.08
13.39%
0.07
10.76%
0.07
4.66%
0.08
14.84%
0
100%
interest coverage
-1.42
-
0.36
125.51%
-0.47
228.33%
-1.19
154.87%
-1.24
4.59%
-97.53
-
interest debt per share
0.26
-
0.01
97.77%
-2.13
36,150.04%
0.07
103.19%
0.22
217.32%
0.10
54.95%
0.69
607.21%
0.47
31.56%
0.43
9.27%
0.14
66.66%
inventory turnover
6.24
-
7.41
18.59%
8.20
10.78%
8.44
2.88%
8.30
1.70%
7.39
10.98%
6.71
9.12%
5.07
24.46%
4.22
16.69%
2.46
41.87%
invested capital
0.11
-
0.08
24.44%
0.03
67.42%
0.01
76.49%
0.00
32.51%
0.05
1,129.59%
0.56
949.71%
0.33
41.13%
0.38
14.33%
0.09
76.41%
market cap
204.29M
-
136.06M
33.40%
310.15M
127.94%
502.90M
62.15%
207.62M
58.72%
185.14M
10.82%
113.52M
38.69%
157.10M
38.40%
117.60M
25.15%
72.76M
38.13%
net current asset value
13.28M
-
20.70M
55.92%
69.13M
233.99%
70.29M
1.68%
62.66M
10.85%
60.84M
2.90%
14.61M
75.99%
25.48M
74.40%
12.96M
49.13%
55.04M
324.71%
net debt to ebitda
-11.02
-
7.98
172.34%
-0.64
107.97%
-0.59
7.19%
-0.57
3.37%
-0.68
20.05%
1.00
246.54%
0.73
27.16%
0.09
87.31%
6.22
6,608.63%
net income per share
-0.23
-
-0.05
78.51%
0.98
2,047.61%
-0.05
105.51%
-0.22
306.72%
-2.09
849.43%
-0.71
65.94%
0.07
110.00%
-0.46
753.74%
0.41
188.82%
operating cash flow per share
-0.04
-
-0.08
104.60%
1.15
1,511.01%
-0.00
100.38%
-0.06
1,216.48%
0.10
274.32%
-0.36
454.86%
0.01
102.23%
-0.34
4,351.27%
-0.75
120.32%
payables turnover
6.58
-
6.25
5.03%
5.80
7.18%
5.75
0.95%
6.35
10.42%
7.98
25.80%
6.15
23.02%
7.90
28.52%
7.65
3.11%
5.45
28.74%
receivables turnover
7.69
-
5.20
32.38%
7.04
35.37%
7.10
0.83%
7.96
12.15%
7.56
5.09%
8.32
10.02%
11.54
38.81%
9.30
19.46%
6.46
30.52%
research and ddevelopement to revenue
0.03
-
0.03
4.85%
0.03
0.10%
0.03
20.79%
0.03
12.87%
0.04
27.60%
0.06
49.58%
0.03
52.79%
0.04
27.37%
0.13
257.25%
return on tangible assets
-0.20
-
-0.04
79.58%
0.45
1,186.39%
-0.03
105.68%
-0.11
334.49%
-1.01
800.20%
-0.32
67.79%
0.03
109.97%
-0.26
890.38%
0.17
165.18%
revenue per share
2.25
-
2.15
4.54%
2.23
3.48%
2.33
4.45%
2.23
4.15%
1.71
23.10%
1.59
7.02%
2.44
53.28%
2.20
9.81%
0.63
71.32%
roe
-0.27
-
-0.05
80.14%
0.51
1,042.90%
-0.03
105.57%
-0.13
351.56%
-1.15
802.50%
-0.58
49.44%
0.05
108.60%
-0.41
930.17%
0.26
162.37%
roic
-0.25
-
-0.03
89.48%
0.49
2,003.04%
-0.04
107.14%
-0.13
281.52%
-34.06
25,243.27%
-0.25
99.27%
0.04
115.70%
-0.21
634.73%
-0.41
96.15%
sales general and administrative to revenue
0.44
-
0.42
3.41%
0.42
0.79%
0.41
3.74%
0.42
4.02%
0.55
28.42%
0.38
-
0.50
31.51%
0.88
74.59%
shareholders equity per share
0.87
-
0.94
8.20%
1.94
106.56%
1.92
1.18%
1.73
9.93%
1.82
5.20%
1.22
32.63%
1.42
16.27%
1.12
21.25%
1.60
42.41%
stock based compensation to revenue
0.01
-
0.01
12.80%
0.01
7.41%
0.01
20.13%
0.02
8.71%
0.02
40.95%
0.02
5.29%
0.01
40.21%
0.02
57.01%
0.10
363.94%
tangible asset value
21.39M
-
29.00M
35.57%
77.68M
167.87%
78.53M
1.09%
71.78M
8.59%
77.54M
8.03%
50.39M
35.02%
60.89M
20.84%
47.01M
22.80%
78.46M
66.90%
tangible book value per share
0.50
-
0.64
27.22%
1.68
163.24%
1.69
0.66%
1.53
9.80%
1.64
7.16%
1.06
35.49%
1.26
19.59%
0.97
23.44%
1.60
64.98%
working capital
15.77M
-
22.53M
42.84%
70.83M
214.40%
71.27M
0.63%
63.01M
11.59%
65.44M
3.86%
35.96M
45.05%
44.51M
23.75%
29.80M
33.03%
58.47M
96.17%

All numbers in USD (except ratios and percentages)